Stock listing
NASDAQ:LABP Landos Biopharma Inc Stock
Follow Landos Biopharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:LABP
$22.93 USD
Close on May 23, 2024 · No longer trades
- Lowest – highest close
- $2.75 – $22.93 USDSince May 26, 2023 · lowest Jun 1, 2023 · highest May 23, 2024
Delisted NASDAQ:LABP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LABP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Landos Biopharma Inc on 6ix
- Decks
- 6 decks · latest Mar 25, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2024) | Merger or acquisition | 12 slides | Mar 25, 2024 |
| Investor Presentation (January 2024) | Investor deck | 31 slides | Jan 4, 2024 |
| Investor Presentation (May 2023) | Investor deck | 23 slides | May 12, 2023 |
| Investor Presentation (February 2023) | Investor deck | 21 slides | Feb 28, 2023 |
| Investor Presentation (January 2023) | Investor deck | 37 slides | Jan 5, 2023 |
| Technical Presentation (August 2022) | Technical | 16 slides | Aug 11, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph Edelman Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Immatics N.V. (Director · Since at least Mar 18, 2026); Solid Biosciences Inc. (Director · Since at least Mar 23, 2021); MeiraGTx Holdings plc (Director · Since at least Nov 23, 2020); LeonaBio, Inc. (Director · Since at least Sep 17, 2020); Adagio Medical Holdings, Inc (Director · Jan 22, 2025 – Jan 22, 2025 · Past); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); ARYA Sciences Acquisition Corp V (Director · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past); Astria Therapeutics Inc (Director · Jan 28, 2021 – Feb 1, 2024 · Past); Nautilus Biotechnology, Inc. (Director · Aug 6, 2020 – Jun 14, 2024 · Past); Cerevel Therapeutics Holdings Inc (Director · Jun 4, 2020 – Feb 20, 2024 · Past); Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – May 31, 2023 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Oct 5, 2018 · Past) | Director · Feb 3, 2021 – Aug 27, 2021 · Past |
| Konstantin Poukalov Other companies: ARYA Sciences Acquisition Corp V (Chief Business Officer · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Chief Business Officer · Feb 25, 2021 – Jul 31, 2024 · Past); Nautilus Biotechnology, Inc. (Chief Business Officer · Aug 6, 2020 – Aug 6, 2020 · Past); Cerevel Therapeutics Holdings Inc (Chief Business Officer · Jun 4, 2020 – Jun 4, 2020 · Past); Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – Jun 13, 2024 · Past); Kadmon Holdings Inc (Executive Vice President, CFO · Jul 26, 2016 – Dec 8, 2017 · Past) | Director · Feb 3, 2021 – Feb 8, 2021 · Past |
| Roderick Wong Other companies: Allurion Technologies, Inc. (Director · Since at least Apr 16, 2025); Rocket Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2018); Orchestra BioMed Holdings, Inc. (Chief Executive Officer, Director · Aug 3, 2020 – Jan 24, 2023 · Past); Avidity Biosciences, Inc (MP and CIO · Jun 11, 2020 – Aug 4, 2021 · Past); Immunovant, Inc. (Chief Executive Officer, Director · May 9, 2019 – Dec 11, 2019 · Past); Penwest Pharmaceuticals Co (Director · Jun 30, 2010 – Sep 20, 2010 · Past) | Director · Feb 3, 2021 – Feb 4, 2021 · Past |
| Timothy M Mayleben Other companies: Loxo Oncology Inc (Director · Jul 28, 2015 – Feb 15, 2019 · Past); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Feb 7, 2025 · Past); Esperion Therapeutics, Inc. (President & CEO, Director · Jun 25, 2013 – Jan 28, 2021 · Past); Vericel Corporation (President and CEO, Director · Oct 17, 2008 – Aug 29, 2012 · Past) | Director · May 13, 2021 – May 23, 2024 · Past |
| Fred Callori Other companies: LeonaBio, Inc. (Director · Since at least May 5, 2026); Astria Therapeutics Inc (Director · Since at least Jan 28, 2021) | Director · Aug 27, 2021 – May 23, 2024 · Past |
| Roger Adsett Other companies: Definium Therapeutics, Inc. (Director · Since at least Jan 29, 2026); Insmed Incorporated (Chief Operating Officer · Since at least Sep 27, 2016) | Director · Mar 8, 2022 – May 23, 2024 · Past |
| Gregory Oakes Other companies: GridAI Technologies Corp. (Director · Apr 13, 2020 – Jan 3, 2022 · Past) | Chief Executive Officer, Director · Jun 20, 2022 – May 23, 2024 · Past |
| Tiago Girão Other companies: Immunovant, Inc. (Chief Financial Officer · Since at least Apr 21, 2025) | Director · Apr 8, 2021 – May 23, 2024 · Past |
| Alka Batycky | Director · May 30, 2023 – May 23, 2024 · Past |
| Christopher Nishan Garabedian | Director · Feb 3, 2021 – May 23, 2024 · Past |
All 17 people
| Person | Seat |
|---|---|
| Fabio Cataldi | Chief Medical Officer · Sep 5, 2022 – May 23, 2024 · Past |
| Jean-Frederic Colombel | Director · Feb 3, 2021 – Feb 3, 2021 · Past |
| Josep Bassaganya-Riera | Chairman, President and CEO, Director · Feb 3, 2021 – Feb 3, 2021 · Past |
| Jyoti Chauhan | ED, Global Clinical Operations · Feb 3, 2021 – Jul 26, 2021 · Past |
| Patricia L Bitar | Interim CFO · Nov 6, 2021 – Dec 17, 2021 · Past |
| Patrick Truesdell | Vice President and Controller · May 16, 2022 – Feb 28, 2023 · Past |
| Raquel Hontecillas | Chief Scientific Officer · Feb 3, 2021 – Feb 3, 2021 · Past |
Log in to ask 6ix AI your own questions about Landos Biopharma Inc.